294 related articles for article (PubMed ID: 14140033)
1. TRIPERIDOL (A PRELIMINARY REPORT).
O'REILLY PO; O'REGAN JB; LIOANAG EM
Dis Nerv Syst; 1964 Apr; 25():221-4. PubMed ID: 14140033
[No Abstract] [Full Text] [Related]
2. [CLINICAL EXPERIMENTATION WITH TRIPERIDOL].
DIPIAZZA P; GORI EC; LEVI-MINZI S
Rass Studi Psichiatr; 1963; 52():595-603. PubMed ID: 14116057
[No Abstract] [Full Text] [Related]
3. [EXPERIMENTS WITH THE ANTI-PARKINSON AGENT BENZTROPINE RECENTLY INTRODUCED IN FRANCE].
SCHEWEICH M; POYART E; BAIL P; LOUIS MC
Ann Med Psychol (Paris); 1963 Dec; 121():771-8. PubMed ID: 14101924
[No Abstract] [Full Text] [Related]
4. [C.B. 8089 (FLUORIZED BUTYROPHENONE) IN STATES OF PSYCHOMOTOR AGITATION AND IN CHARACTER DISORDERS AT ALL AGES (EXCEPT CHILDHOOD)].
CHATAGNON PA; CHATAGNON C
Ann Med Psychol (Paris); 1964 May; 122():809-16. PubMed ID: 14150706
[No Abstract] [Full Text] [Related]
5. [A NEW MAJOR NEUROLEPTIC AGENT: TRIPERIDOL. 1ST CLINICAL RESULTS OBTAINED WITH A NEW BUTYROPHENONE DERIVATIVE].
DUBOIS C; DICK P; REY-BELLET J
Schweiz Med Wochenschr; 1963 Nov; 93():1600-4. PubMed ID: 14153115
[No Abstract] [Full Text] [Related]
6. A CLINICAL COMPARISON OF TRIFLUPERIDOL, HALOPERIDOL, AND CHLORPROMAZINE.
FOX W; GOBBLE IF; CLOS M; DENISON E
Curr Ther Res Clin Exp; 1964 Jun; 6():409-15. PubMed ID: 14200303
[No Abstract] [Full Text] [Related]
7. REPORT ON THE TREATMENT OF PSYCHOTIC PATIENTS WITH SORDINOL.
SEGERS J; SCHUNZELAAR K; NUYTS SA
Acta Neurol Psychiatr Belg; 1964 Jul; 64():746-52. PubMed ID: 14212721
[No Abstract] [Full Text] [Related]
8. CLINICAL TRIAL OF A POTENTIATED DIKETOPIPERAZINE DERIVATIVE AS A PSYCHOPHARMACOLOGICAL AGENT FOR THE TREATMENT OF PSYCHOTIC PATIENTS.
GERSON IM; CHAT E; TWIGGER NA
Am J Psychiatry; 1964 Aug; 121():179-81. PubMed ID: 14196596
[No Abstract] [Full Text] [Related]
9. A LONG-TERM CLINICAL EVALUATION OF A NEW TRANQUILLIZER--TOLNATE.
FISMER DF
S Afr Med J; 1964 Nov; 38():911-3. PubMed ID: 14225676
[No Abstract] [Full Text] [Related]
10. EXPERIENCE WITH DIAZEPAM IN AN ELECTROENCEPHALOGRAPHY LABORATORY CONTROLLED EVALUATION.
METCALF DR; WHITLEY DJ
Am J Psychiatry; 1964 May; 120():1114-5. PubMed ID: 14144439
[No Abstract] [Full Text] [Related]
11. PSYCHOSES CAUSED BY NEUROLEPTICS.
STROEMGREN E
Encephale; 1964; 53():SUPPL:170-4. PubMed ID: 14161529
[No Abstract] [Full Text] [Related]
12. SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.
BISHOP MP; GALLANT DM
Arch Gen Psychiatry; 1965 Aug; 13():155-62. PubMed ID: 14314761
[No Abstract] [Full Text] [Related]
13. NEURODYSLEPTIC THERAPY. CLINICAL TRIALS IN CHRONIC SCHIZOPHRENIA WITH A NEW BUTYROPHENONE DERIVATIVE R-2498.
MADALENA JC
Hospital (Rio J); 1964 Dec; 66():1207-25. PubMed ID: 14252207
[No Abstract] [Full Text] [Related]
14. [EARLY CLINICAL EVALUATION OF THE NEUROLEPTIC PROPERTIES OF A NEW COMPOUND: DIBENZOTHIAZEPINE].
DELAY J; DENIKER P; GINESTET D; P'ERON MAGNAN P
Ann Med Psychol (Paris); 1964 Oct; 122():402-7. PubMed ID: 14205902
[No Abstract] [Full Text] [Related]
15. [CLINICAL ASPECTS OF HALOPERIDOL].
GERLE B
Nord Psykiatr Tidsskr; 1964; 18():68-74. PubMed ID: 14132837
[No Abstract] [Full Text] [Related]
16. A CLINICAL TRIAL OF CI-383 AND CI-384 IN PSYCHOTIC PATIENTS.
JACOBS H; GLEN F
J Neuropsychiatr; 1964 Apr; 5():235-43. PubMed ID: 14147035
[No Abstract] [Full Text] [Related]
17. [1ST CLINICAL RESULTS OF A NEW ANTI-ANXIETY AGENT, RO5-2807].
BOUTILLIER ; RAYBAUD ; CORSETTI ; DUCAMIN JP
Ann Med Psychol (Paris); 1963 Oct; 121():397-404. PubMed ID: 14133836
[No Abstract] [Full Text] [Related]
18. TRIPERIDOL IN SCHIZOPHRENIA: FURTHER EVIDENCE FOR SPECIFIC PATTERNS OF ACTION OF ANTIPSYCHOTIC DRUGS.
HOLLISTER LE; OVERALL JE; BENNETT JL; KIMBELL I; SHELTON J
J New Drugs; 1965; 5(1):34-42. PubMed ID: 14283066
[No Abstract] [Full Text] [Related]
19. [PRELIMINARY CLINICAL EVALUATION OF RO 5-3608. COMPARISON WITH TRIHEXAPHENIDYL IN MEDICINAL PARKINSONISM].
MADALENA JC
Folha Med; 1965 Feb; 50():119-23. PubMed ID: 14347357
[No Abstract] [Full Text] [Related]
20. STUDY OF PASPALUM SCROBICULATUM EXTRACT IN FORTY PSYCHOTIC PATIENTS.
DEO VR
Psychopharmacologia; 1964 Feb; 5():228-33. PubMed ID: 14138758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
